4D Molecular Therapeutics

4DMT is focused on the discovery and development of targeted, customized and proprietary next-generation AAV gene therapy products for use in patients with severe genetic diseases with high unmet medical need. Their robust discovery platform, termed Therapeutic Vector Evolution, empowers the company to create customized gene delivery vehicles to deliver genes specifically to any tissue or organ in the body, by optimal clinical routes of administration, at lower doses and with resistance to pre-existing antibodies. These proprietary and targeted products allow 4DMT to treat both rare genetic diseases and complex large market diseases.

4D Molecular Therapeutics

Emeryville, CA

Website

08.19.2020
4D Molecular Therapeutics Announces First Patient Dosed in Phase …

Read More

06.16.2020
4D Molecular Therapeutics Raises $75 Million in Series C Financin…

Read More